Retatrutide is an investigational GLP-1, GIP, and glucagon triple receptor agonist that has not received MHRA or EMA approval and holds no UK marketing authorisation
This approach works best for men with secondary hypogonadism where the testes function normally but lack adequate stimulation
Although direct experiments specifically exposing human granulosa/cumulus cells to NET preparations remain limited, convergent evidence supports a mechanistic chain in which NET-derived proteases and ROS can (a) impair mitochondrial respiration and membrane potential
In this blog, well explore what they are, how they work, and how incorporating them into your health routine can lead to transformative results
After a head injury, the brain produces a surge of free radicals and inflammatory molecules that can prolong symptoms
Book a Glutathione IV Therapy Consultation We begin with a medical consultation to confirm suitability and clarify your goals